Abbott Laboratories (ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	225,302	196,184	191,088	191,427	241,365	187,600
Market Cap Growth	15.18%	2.67%	-0.18%	-20.69%	28.66%	22.13%
Enterprise Value	229,332	203,674	199,953	198,309	250,286	201,641
Last Close Price	133.27	111.01	105.91	103.57	130.57	100.03
PE Ratio	16.26	14.69	33.52	27.72	34.28	41.94
Forward PE	23.31	22.39	24.22	26.64	30.05	23.93
PS Ratio	5.29	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.59	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	10.78	10.96	31.28	55.76	-	-
P/FCF Ratio	-	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	-	22.92	26.32	19.98	22.92	23.74
PEG Ratio	2.50	2.61	2.85	5.16	2.38	2.06
EV/Sales Ratio	5.23	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	19.90	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	27.35	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	-	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.27	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.12	1.38	1.48	1.41	1.47	2.18
Debt / FCF Ratio	-	2.41	3.16	2.30	2.23	3.48
Asset Turnover	-	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	-	2.92	2.81	3.37	3.56	3.22
Quick Ratio	-	1.05	1.00	1.06	1.28	1.14
Current Ratio	-	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	-	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	-	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	8.88%	7.94%	8.23%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	-	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	6.24%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	-	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	1.82%	2.02%	1.96%	1.85%	1.39%	1.53%
Payout Ratio	29.60%	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.03%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Shareholder Return	1.87%	2.08%	2.81%	3.25%	1.23%	1.25%

Updated Oct 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q